Neurology News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 50 articles
Hillhurst Bio doses first subject in Phase 2a HBI-002 Parkinson's trial
Neurocrine Biosciences pipeline update: what analysts should watch next
AI and Brain Organoids Combat Parkinson's and Rare Epilepsy
CAPLYTA (Lumateperone) Ranks Highest Among FDA-Approved Adjunctive Depression Treatments in Network Meta-Analysis
InspireMD Receives FDA Approval for SwitchGuard Neuro Protection System CGUARDIANS III Pivotal Trial
Clene's CNM-Au8 Gets FDA Green Light for Accelerated Approval Pathway in ALS Treatment
Novartis Receives Health Canada Approval for Fabhalta Oral Treatment for C3G Patients
Akebia Therapeutics Vadadustat Shows Significant Mortality Reduction in New Kidney Disease Analysis
Spinogenix Tazbentetol Shows Neuroprotective Effects in Glaucoma and Diabetic Retinopathy Preclinical Studies at ARVO 2026
Axsome FDA Approval for Alzheimer's Agitation Drug
Rhythm Pharmaceuticals' IMCIVREE Receives European Commission Approval for Acquired Hypothalamic Obesity
ZETA SURGICAL Receives FDA 510(k) Clearance for Brain Surgery Navigation System